Evidence map›Paper›PMID 40388041›Full record

ArticleMolecular biology reports2025

Alteration in Ca

Mohammad Taheri, Ashkan Pourtavakoli, Vidasadat Seyyedesfahani, Solat Eslami, Arezou Sayad, Soudeh Ghafouri-Fard

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohammad TaheriInstitute of Human Genetics, Jena University Hospital, Jena, Germany.
Ashkan PourtavakoliPhytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Vidasadat SeyyedesfahaniDepartment of Biotechnology, Bangalore North University, Bangalore, India.
Solat EslamiDepartment of Medical Biotechnology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Arezou SayadDepartment of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ar.sayad@yahoo.com.
Soudeh Ghafouri-FardDepartment of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. s.ghafourifard@sbmu.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCalcium (Ca METHODS AND

resultsWe have investigated expression levels of SLC1A1, SLC25A12, and ATP2B2 genes from Ca

conclusionsCumulatively, we demonstrated aberrations in the expression of Ca

Indexed as

Calcium SignalingSchizophreniaAdultCalciumCase-Control StudiesExcitatory Amino Acid Transporter 3FemaleHumansMaleMiddle AgedPlasma Membrane Calcium-Transporting ATPasesRNA, Long NoncodingCalciumExcitatory Amino Acid Transporter 3Plasma Membrane Calcium-Transporting ATPasesRNA, Long NoncodingSLC1A1 protein, humanCalcium signalingLncRNASchizophrenia

Identifiers

PMID40388041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.